Welcome to our dedicated page for MICROCHIP TECHNOLOGY SEC filings (Ticker: MCHPP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MICROCHIP TECHNOLOGY's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MICROCHIP TECHNOLOGY's regulatory disclosures and financial reporting.
Microchip Technology (MCHP) director, president, CEO and chair Steve Sanghi reported two indirect open‑market sales of common stock by entities associated with him under a Rule 10b5‑1 trading plan. On April 30, 2026, 33,502 shares were sold at an average price of $92.3729 per share. On May 1, 2026, 76,469 shares were sold at an average price of $93.5843 per share, for total reported sales of 109,971 shares. After these transactions, 9,385,834 shares of Microchip Technology common stock are reported as indirectly held, including shares held by The Sanghi Trust and The Sanghi Family Limited Partnership.
Microchip Technology (MCHP) director, president, CEO and chair Steve Sanghi reported two indirect open‑market sales of common stock by entities associated with him under a Rule 10b5‑1 trading plan. On April 30, 2026, 33,502 shares were sold at an average price of $92.3729 per share. On May 1, 2026, 76,469 shares were sold at an average price of $93.5843 per share, for total reported sales of 109,971 shares. After these transactions, 9,385,834 shares of Microchip Technology common stock are reported as indirectly held, including shares held by The Sanghi Trust and The Sanghi Family Limited Partnership.
Microchip Technology reported insider sale activity by Steve Sanghi via Form 144. The filing lists three sales in the past three months: 94,869 shares on 02/12/2026 for $7,823,191.83, 416,581 shares on 04/23/2026 for $36,880,749.10, and 33,502 shares on 04/30/2026 for $3,094,676.90. The filing also shows prior option exercises (37,920; 25,000) and an RSU vesting (13,549).
Microchip Technology reported insider sale activity by Steve Sanghi via Form 144. The filing lists three sales in the past three months: 94,869 shares on 02/12/2026 for $7,823,191.83, 416,581 shares on 04/23/2026 for $36,880,749.10, and 33,502 shares on 04/30/2026 for $3,094,676.90. The filing also shows prior option exercises (37,920; 25,000) and an RSU vesting (13,549).
Microchip Technology (MCHP) notice of proposed sale: the filing lists proposed sales of Common Stock under Rule 144 and discloses prior sales during the past three months by Steve Sanghi. The excerpt shows prior disposals of 94,869 shares on 02/12/2026 and 416,581 shares on 04/23/2026 with reported aggregate values of $7,823,191.83 and $36,880,749.10, respectively.
The filing also references a block of 33,502 shares tied to an option exercise (11/14/2012) and lists Fidelity Brokerage Services LLC as a broker address. The notice is a routine regulatory disclosure of proposed resale activity under Rule 144.
Microchip Technology (MCHP) notice of proposed sale: the filing lists proposed sales of Common Stock under Rule 144 and discloses prior sales during the past three months by Steve Sanghi. The excerpt shows prior disposals of 94,869 shares on 02/12/2026 and 416,581 shares on 04/23/2026 with reported aggregate values of $7,823,191.83 and $36,880,749.10, respectively.
The filing also references a block of 33,502 shares tied to an option exercise (11/14/2012) and lists Fidelity Brokerage Services LLC as a broker address. The notice is a routine regulatory disclosure of proposed resale activity under Rule 144.
Vanguard Capital Management files a Schedule 13G reporting beneficial ownership of 7.50% of Microchip Technology Inc common stock. The filing states Vanguard Capital Management beneficially owns 40,620,884 shares and reports sole dispositive power over 40,620,884 shares and sole voting power for 5,495,811 shares as of 03/31/2026. The filing notes ownership includes securities held for Vanguard funds and managed accounts under the reporting business unit. The filing is signed by Vanguard's Head of Global Fund Administration on 04/30/2026.
Vanguard Capital Management files a Schedule 13G reporting beneficial ownership of 7.50% of Microchip Technology Inc common stock. The filing states Vanguard Capital Management beneficially owns 40,620,884 shares and reports sole dispositive power over 40,620,884 shares and sole voting power for 5,495,811 shares as of 03/31/2026. The filing notes ownership includes securities held for Vanguard funds and managed accounts under the reporting business unit. The filing is signed by Vanguard's Head of Global Fund Administration on 04/30/2026.
Vanguard Portfolio Management reported beneficial ownership of 32,469,341 shares of Microchip Technology Inc. common stock, representing 6% of the class as of 03/31/2026. The filing shows sole voting power for 63,962 shares and sole dispositive power for 32,469,341 shares. The report is signed by Ashley Grim on 04/29/2026.
Vanguard Portfolio Management reported beneficial ownership of 32,469,341 shares of Microchip Technology Inc. common stock, representing 6% of the class as of 03/31/2026. The filing shows sole voting power for 63,962 shares and sole dispositive power for 32,469,341 shares. The report is signed by Ashley Grim on 04/29/2026.
Microchip Technology President, CEO and Chair Steve Sanghi reported an open-market sale of 416,581 shares of Common Stock at $88.5329 per share under a pre-arranged Rule 10b5-1 trading plan. After this indirect sale through a trust and a family limited partnership, he continues to hold 9,495,805 shares indirectly.
Microchip Technology President, CEO and Chair Steve Sanghi reported an open-market sale of 416,581 shares of Common Stock at $88.5329 per share under a pre-arranged Rule 10b5-1 trading plan. After this indirect sale through a trust and a family limited partnership, he continues to hold 9,495,805 shares indirectly.
Microchip Technology reports proposed insider sales via Form 144. The filing lists planned dispositions of common stock tied to vested RSUs and option exercises and shows two recent sale filings: 94,869 shares on 02/12/2026 and 98,814 shares on 01/28/2026. The filing names Fidelity Brokerage Services LLC as broker.
Microchip Technology reports proposed insider sales via Form 144. The filing lists planned dispositions of common stock tied to vested RSUs and option exercises and shows two recent sale filings: 94,869 shares on 02/12/2026 and 98,814 shares on 01/28/2026. The filing names Fidelity Brokerage Services LLC as broker.
Microchip Technology chief operating officer Richard J. Simoncic reported new equity awards and an ownership correction. On April 1, 2026, he received grants of restricted stock units and performance stock units covering 10,667, 8,089 and 4,779 restricted units and 10,667, 8,090 and 4,780 performance units, each representing the right to receive one share of common stock.
The restricted units vest over quarterly schedules from May 15, 2027 through February 15, 2029, with another grant vesting in full on May 15, 2030. The performance units are tied to cumulative non-GAAP operating margin targets of 30.5%, 31.0% and 31.5% over measurement periods ending March 31, 2027, March 31, 2028 and March 31, 2029, with vesting dates matching the related restricted units.
The filing also shows a bona fide gift of 1,075 common shares on May 15, 2024, held indirectly by a trust, and corrects previously reported beneficial ownership to 146,127 common shares for that indirect position.
Microchip Technology chief operating officer Richard J. Simoncic reported new equity awards and an ownership correction. On April 1, 2026, he received grants of restricted stock units and performance stock units covering 10,667, 8,089 and 4,779 restricted units and 10,667, 8,090 and 4,780 performance units, each representing the right to receive one share of common stock.
The restricted units vest over quarterly schedules from May 15, 2027 through February 15, 2029, with another grant vesting in full on May 15, 2030. The performance units are tied to cumulative non-GAAP operating margin targets of 30.5%, 31.0% and 31.5% over measurement periods ending March 31, 2027, March 31, 2028 and March 31, 2029, with vesting dates matching the related restricted units.
The filing also shows a bona fide gift of 1,075 common shares on May 15, 2024, held indirectly by a trust, and corrects previously reported beneficial ownership to 146,127 common shares for that indirect position.
Sanghi Steve reported acquisition or exercise transactions in this Form 4 filing.
Microchip Technology president, CEO and chair Steve Sanghi reported new equity awards in the form of restricted stock units (RSUs) and performance stock units (PSUs) granted at no cash cost on April 1, 2026. The RSUs cover 53,643 shares of common stock and the PSUs cover 80,462 target shares.
The RSUs vest on schedules running from May 15, 2028 through February 15, 2030, as long as he remains a service provider, with shares delivered upon vesting. The PSUs are tied to Microchip’s cumulative non-GAAP operating margin over 4, 8 and 12-quarter periods ending March 31, 2027, 2028 and 2029, with actual shares earned potentially above or below target and vesting through May 15, 2030. The filing also notes 9,912,386 common shares held indirectly via a trust and a family limited partnership.
Sanghi Steve reported acquisition or exercise transactions in this Form 4 filing.
Microchip Technology president, CEO and chair Steve Sanghi reported new equity awards in the form of restricted stock units (RSUs) and performance stock units (PSUs) granted at no cash cost on April 1, 2026. The RSUs cover 53,643 shares of common stock and the PSUs cover 80,462 target shares.
The RSUs vest on schedules running from May 15, 2028 through February 15, 2030, as long as he remains a service provider, with shares delivered upon vesting. The PSUs are tied to Microchip’s cumulative non-GAAP operating margin over 4, 8 and 12-quarter periods ending March 31, 2027, 2028 and 2029, with actual shares earned potentially above or below target and vesting through May 15, 2030. The filing also notes 9,912,386 common shares held indirectly via a trust and a family limited partnership.
Krawczyk Joseph R II reported acquisition or exercise transactions in this Form 4 filing.
Microchip Technology senior vice president Joseph R. Krawczyk II received multiple equity awards in the form of restricted stock units (RSUs) and performance stock units (PSUs) on April 1, 2026. These units each represent a contingent right to receive one share of Microchip common stock.
The RSUs vest over time in quarterly installments between May 15, 2027 and February 15, 2030, provided he continues as a service provider through each vesting date. Vested RSU shares will be delivered upon vesting.
The PSUs are tied to Microchip’s cumulative non-GAAP operating margin over 4, 8, or 12-quarter measurement periods ending on March 31, 2027, March 31, 2028, and March 31, 2029, with target outcomes based on margin levels of 30.5%, 31.0%, and 31.5%. Actual shares earned can be higher or lower than target depending on performance, and earned PSUs vest in quarterly tranches or in full from May 15, 2027 through May 15, 2030. Following these awards, he directly holds 13,926 shares of common stock.
Krawczyk Joseph R II reported acquisition or exercise transactions in this Form 4 filing.
Microchip Technology senior vice president Joseph R. Krawczyk II received multiple equity awards in the form of restricted stock units (RSUs) and performance stock units (PSUs) on April 1, 2026. These units each represent a contingent right to receive one share of Microchip common stock.
The RSUs vest over time in quarterly installments between May 15, 2027 and February 15, 2030, provided he continues as a service provider through each vesting date. Vested RSU shares will be delivered upon vesting.
The PSUs are tied to Microchip’s cumulative non-GAAP operating margin over 4, 8, or 12-quarter measurement periods ending on March 31, 2027, March 31, 2028, and March 31, 2029, with target outcomes based on margin levels of 30.5%, 31.0%, and 31.5%. Actual shares earned can be higher or lower than target depending on performance, and earned PSUs vest in quarterly tranches or in full from May 15, 2027 through May 15, 2030. Following these awards, he directly holds 13,926 shares of common stock.